Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy

尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略

基本信息

项目摘要

Abstract The “Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy” (TASSH NIMR) parent study is an ongoing clinical effectiveness implementation trial that evaluates the effectiveness of an implementation strategy to integrate a task-strengthening strategy for hypertension control (TASSH) in HIV clinics in Lagos State (R01HL147811). In response to NOT-OD-21-020, we propose this administrative supplement, “Establishing an Ethics Learning Collaborative for HIV-Hypertension Integration through a TAsk Strengthening Strategy for Hypertension Control in Lagos State, Nigeria” (E-LinC TASSH). E-LinC TASSH will leverage the TASSH NIMR Steering Committee to form an Ethics Learning Collaborative (ELC), which will identify, analyze, and characterize ethical considerations for implementing a practice facilitation–guided task- strengthening approach to couple hypertension and HIV treatment within primary health care centers throughout Lagos State. Additionally, E-LinC TASSH will develop an ethics-informed strategy for scaling up, spreading, and sustaining the TASSH NIMR intervention in HIV clinics throughout Lagos State. To better appreciate an implementation research informed learning collaboratives to advance bioethical considerations in HIV- hypertension integration, this supplement will also evaluate use of an ethics focused learning collaborative. Expansion into this area of bioethics research will allow us to comprehensively understand and contextualize ethical considerations of implementing this treatment and management model. This bioethics research will enable us to develop strategies for managing and solving ethical challenges arising in our implementation research and scale-up of the TASSH NIMR strategy. TASSH NIMR is currently in the pre-implementation or planning phase and will begin recruitment in time for the proposed research to enhance the intervention's impact and to inform the next steps for scaling up, spreading, and sustaining the intervention within the Lagos State primary healthcare network. In addition to engaging in the proposed bioethics research, E-LinC TASSH will build research ethics and bioethics capacity among ELC members through expert-facilitated discussions and activities involved in developing the survey, engaging stakeholders, interpreting findings, and integrating this new knowledge into practical strategies. Per instructions in NOT-OD-21-020, this supplement is specific to bioethics research and capacity building.
摘要 "将高血压管理纳入尼日利亚的艾滋病护理:一项任务强化战略"(TASSH NIMR)母研究是一项正在进行的临床有效性实施试验, 实施战略,将艾滋病毒高血压控制任务强化战略(TASSH)纳入其中 拉各斯州的诊所(R01HL 147811)。为响应NOT-OD-21 - 020,我们建议 补充,"通过TAsk建立艾滋病毒-高血压整合的伦理学学习协作 加强尼日利亚拉各斯州高血压控制战略"(E-LinC TASSH)。E-LinC TASSH将 利用TASSH NIMR指导委员会组建道德学习协作组织(ELC),该组织将 识别、分析和描述实施实践引导任务的伦理考虑因素- 加强各级初级卫生保健中心对高血压和艾滋病毒的联合治疗 拉各斯州。此外,E-LinC TASSH将制定一项基于道德的战略,以扩大、推广和 在整个拉各斯州的艾滋病毒诊所持续开展TASH NIMR干预活动。为了更好地欣赏 实施研究为学习合作者提供信息,以促进艾滋病毒方面的生物伦理考虑- 高血压的整合,这一补充也将评估使用的伦理学为重点的学习协作。 扩展到生物伦理学研究的这一领域将使我们能够全面理解和背景化 实施这种治疗和管理模式的道德考虑。这项生物伦理学研究将 使我们能够制定战略,以管理和解决我们实施过程中出现的道德挑战 研究和扩大TASSH NIMR战略。TASSH NIMR目前处于预实施阶段或 规划阶段,并将开始招聘的时间为拟议的研究,以加强干预的影响 并为下一步在拉各斯州内扩大、推广和维持干预提供信息 初级保健网。除了从事拟议的生物伦理学研究外,E-LinC TASSH还将建立 通过专家主持的讨论和活动,提高ELC成员的研究伦理和生物伦理能力 参与制定调查,参与利益相关者,解释调查结果,并将新的 将知识转化为实际战略。 根据NOT-OD-21 - 020中的说明,本附录专门针对生物伦理学研究和能力建设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OLIVER CHUKWUJEKWU EZECHI其他文献

OLIVER CHUKWUJEKWU EZECHI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OLIVER CHUKWUJEKWU EZECHI', 18)}}的其他基金

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST)
维持创新工具以扩大青少年友好型艾滋病毒自我检测 (S-ITEST)
  • 批准号:
    10933892
  • 财政年份:
    2024
  • 资助金额:
    $ 13.59万
  • 项目类别:
Innovative Tools to Expand Music-Inspired Strategies for Blood Pressure and Stroke Prevention (I-TEST BP/Stroke)
扩展受音乐启发的血压和中风预防策略的创新工具(I-TEST BP/中风)
  • 批准号:
    10937709
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)
美国-尼日利亚癌症控制实施科学与公平研究中心 (C3-RISE)
  • 批准号:
    10738439
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV)
HPV 社区参与协作策略行动 (ACCESS HPV)
  • 批准号:
    10708926
  • 财政年份:
    2022
  • 资助金额:
    $ 13.59万
  • 项目类别:
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV)
HPV 社区参与协作策略行动 (ACCESS HPV)
  • 批准号:
    10587502
  • 财政年份:
    2022
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10491843
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10701767
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
抗逆转录病毒免疫重建骨丢失的预测因素 - 肠道和微生物组
  • 批准号:
    10326900
  • 财政年份:
    2021
  • 资助金额:
    $ 13.59万
  • 项目类别:
Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy
尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略
  • 批准号:
    10337310
  • 财政年份:
    2020
  • 资助金额:
    $ 13.59万
  • 项目类别:
Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy
尼日利亚将高血压管理纳入艾滋病毒护理:任务强化策略
  • 批准号:
    9926582
  • 财政年份:
    2020
  • 资助金额:
    $ 13.59万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 13.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了